CON News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CO

Mkt Cap

$4.99B

Volume

1.01M

Next Earnings

November 5th

Chart Financials Earnings News About Dividends Insider Filings

CON vs. MEDP: Which Stock Should Value Investors Buy Now?In a comparison of two Medical Services stocks, Concentra Group (CON) emerges as the superior value option compared to Medpace (MEDP). CON holds a Zacks Rank of #2 (Buy) with improving earnings outlook and more attractive valuation metrics, including a forward P/E of 22.74 versus MEDP's 34.77, and a PEG ratio of 1.37 versus 2.72. CON also received a Value grade of B compared to MEDP's D grade.Zacks Investment Research · Oct 14, 2026

Encompass Health Expands Rehab Footprint With New Maine HospitalEncompass Health Corporation (EHC) opened its first wholly owned hospital in Maine with 50 inpatient rehabilitation beds. Q2 2026 discharges rose 5.6% year-over-year, driven by new capacity and 2.8% same-store growth. EHC opened three hospitals in the first half of 2026 and plans to open eight new hospitals throughout the year, reflecting its strategy to expand capacity in favorable markets.Zacks Investment Research · Oct 7, 2026

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?Concentra Group (CON) has reached a new 52-week high of $36.05, gaining 82% year-to-date and outperforming its sector. The company maintains a Zacks Rank #1 (Strong Buy) with consistent earnings beat records and a VGM Score of B. However, valuation metrics show the stock trades at a premium to peers (21.7X forward P/E vs. 17X industry average), raising questions about further upside potential.Zacks Investment Research · Sep 15, 2026

CON vs. MEDP: Which Stock Is the Better Value Option?A comparison of two Medical Services sector stocks reveals that Concentra Group (CON) is more attractive to value investors than Medpace (MEDP). CON has a stronger Zacks Rank (#1 vs #2), lower valuation multiples (forward P/E of 20.95 vs 33.25, PEG ratio of 1.26 vs 2.60, and P/B ratio of 9.04 vs 37.52), and a better Value grade (B vs D), making it the superior option for value-focused investors.Zacks Investment Research · Sep 11, 2026

Concentra (CON) Q2 Revenue Jumps 15%Concentra Group Parent reported Q2 2025 revenue of $550.8 million, a 15.2% year-over-year increase, driven by acquisitions and organic growth. Despite beating revenue estimates, earnings per share missed expectations, and profitability was pressured by higher expenses.The Motley Fool · Aug 8, 2025

Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off ConcentraSelect Medical Holdings Corporation announced a special stock distribution to spin-off its Concentra subsidiary, which is the largest provider of occupational health services in the United States.Benzinga · Nov 6, 2024

Stocks Slip As Oil Prices Climb, 10-Year Yields Cross 4%; Energy Sector Outperforms: What's Driving Markets Monday?Stocks opened lower as geopolitical tensions in the Middle East escalated, driving up oil prices and Treasury yields. The energy sector outperformed, while other sectors declined. Concerns over potential Israeli retaliation against Iran and the ongoing war in Gaza weighed on the market.Benzinga · Oct 7, 2024

CO

CONConcentra Group Holdings Parent, Inc.

CON

Pay with—

Available Balance0.00

Your PositionYou don't own any CON yet.

Related Tickers

Earnings

Dividends

Last · Aug 20Quarterly

Amount$0.0630

Yield0.65%

Annual$0.25